Cell and Gene Outsourcing

  1. Optimization-By-Design — A Critical Factor In Viral Vector Scale Up 12/14/2023

    Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.

  2. Keys To A Successful cGMP Manufacturing Operation Delivering CGTs

    Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of every day, manufacturing operational excellence.

  3. Viral Vector Manufacturing: Improve Efficiency With A Platform Approach 9/25/2023

    Learn more about the platform-based scalable suspension process for LVV production and how it is impacting CGTs advancing toward commercialization.

  4. Early Developability And Analytical Toolbox For The Production Of Multi-Chain Biotherapeutics

    In recent years, the number of biotherapeutic molecules requiring more complex assemblies has greatly increased. Typically, these multi-chain molecules are no longer compatible with platform approaches and require a more agile approach to early developability and method development.

  5. Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats

    Explore an integrated drug substance/drug product CMC strategy and technical case studies that provide insight into delivering product-specific solutions and enabling the acceleration of novel molecular formats.

  6. Revolutionizing How Medicines Are Made, Funded, And Scaled 5/9/2023

    Hear from site leaders and virtually tour the process and analytical development laboratory and GMP manufacturing facility which includes four additional 2,000L single-use bioreactors.

  7. Improved And Rebalanced Plasmids To Ramp Up Your AAV Productivity

    Growth in rAAV-based therapies is creating a need for dramatically increased production. Learn how AAV productivity can be optimized using platform technologies capable of affording significantly higher titers.

  8. Managing Risks In Injectable Drug Delivery 3/13/2025

    Gain insights pertinent to efficient and effective drug development. Understand and execute a risked-based critical thinking approach related to injectable drug packaging and delivery.

  9. Future-Proof Your Aseptic Filling 2/24/2023

    Using the Cytiva SA25 Aseptic Filling Workcell, a standardized system designed with flexibility built in, ensures that companies can pivot between products quickly and adapt as manufacturing needs change.

  10. Quality Agreements: Defining Governance In CDMO Partnerships 5/15/2024

    Quality agreements serve a critical role within a CDMO-Sponsor partnership. Review the importance of aligning objectives, quality standards, and compliance frameworks to establish a robust foundation.